Technical Analysis for BIEI - Premier Biomedical

Grade Last Price % Change Price Change
grade F 0.0005 -50.00% -0.0005
BIEI closed down 50.0 percent on Thursday, November 14, 2019, on 8.77 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BIEI trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Volume Surge Other 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -50.00%

Older signals for BIEI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically focusing the treatment of Cancer, Multiple Sclerosis (MS), Neuropathic Pain, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer's disease (AD), and Blood Sepsis and Viremia. The Company intends to develop its Sequential-Dialysis Technique, to target Cancer, Alzheimer's disease, ALS, Blood Sepsis, Leukemia and other life-threatening cancers. The Sequential-Dialysis Technique is a methodology for the removal of those molecules, which are harmful and responsible for causing diseases. Its Sequential-Dialysis Technique method removes those excitatory neural transmitters that cause the death of those cells. It also intends to develop Feldetrex, a candidate drug, for the treatment of MS, Fibromyalgia and TBI. Feldetrex utilizes a low dosage of Naltrexone to increase endogenous enkephalins10.
Medicine Medical Specialties RTT Cancer Pain Diseases Treatment Of Cancer Cancers Dialysis Multiple Sclerosis Alzheimer's Disease Amyotrophic Lateral Sclerosis Leukemia Fibromyalgia Traumatic Brain Injury Ms Sepsis Als
Is BIEI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.1355
52 Week Low 0.0004
Average Volume 10,920,657
200-Day Moving Average 0.0206
50-Day Moving Average 0.0046
20-Day Moving Average 0.0017
10-Day Moving Average 0.0013
Average True Range 0.0009
ADX 9.97
+DI 21.7822
-DI 24.7525
Chandelier Exit (Long, 3 ATRs ) 0.0017
Chandelier Exit (Short, 3 ATRs ) 0.0031
Upper Bollinger Band 0.0028
Lower Bollinger Band 0.0006
Percent B (%b) -0.05
BandWidth 129.411765
MACD Line -0.0011
MACD Signal Line -0.0012
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0016
Resistance 3 (R3) 0.0016 0.0014 0.0014
Resistance 2 (R2) 0.0014 0.0011 0.0013 0.0013
Resistance 1 (R1) 0.0009 0.0009 0.0008 0.0009 0.0013
Pivot Point 0.0007 0.0007 0.0006 0.0006 0.0007
Support 1 (S1) 0.0002 0.0004 0.0001 0.0002 -0.0003
Support 2 (S2) 0.0000 0.0002 -0.0001 -0.0003
Support 3 (S3) -0.0005 0.0000 -0.0004
Support 4 (S4) -0.0006